13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001697013
申報總市值
US$19.3億
US$19.3億
65 檔
26.4%
Eversept Partners, LP 在 Q4 2024 季度的美股部位總計估值為 US$19.3億，分散於 65 個持倉標的之中，反映其市場參與廣度與投資規模。
從 Q4 2024 申報觀察，Eversept Partners, LP 採取防禦導向的調倉策略，本季減碼 31 檔個股並出清 17 檔部位，顯示機構在該時期進行風險控制與流動性回收。
在資產配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 NTRA, QQQ, GSK 等）合計佔整體申報市值的 26.4%，反映機構在主要關鍵部位上的權重分佈。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 股票-醫療保健 | 12.32% | -1.58% | +0.76% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 11.03% | -3.49% | -2.60% | |
| 3 | GSK | Gsk Plc-spon Adr | 股票-醫療保健 | 10.99% | -3.89% | -9.75% | |
| 4 | VERA | Vera Therapeutics Inc | 股票-其他 | 6.01% | +0.32% | -21.96% | |
| 5 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 4.84% | — | +6.53% | |
| 6 | HCA | Hca Healthcare Inc | 股票-醫療保健 | 4.68% | +0.01% | +36.20% | |
| 7 | TEVA | Teva Pharmaceutical-sp Adr | 股票-醫療保健 | 4.39% | — | -30.68% | |
| 8 | RVTY | Revvity Inc | 股票-醫療保健 | 3.89% | +0.09% | -16.43% | |
| 9 | HQY | Healthequity Inc | 股票-醫療保健 | 3.29% | -0.23% | EXIT | |
| 10 | ZIMV | Zimvie Inc | 股票-其他 | 2.56% | — | — | |
| 11 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 2.33% | +0.37% | NEW | |
| 12 | TECH | Bio-techne CORP | 股票-醫療保健 | 1.91% | -0.28% | -54.89% | |
| 13 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.61% | +0.46% | +27.43% | |
| 14 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股與成長 | 1.55% | -3.67% | EXIT | |
| 15 | VTRS | Viatris Inc | 股票-醫療保健 | 1.41% | — | -26.31% | |
| 16 | TLT | Ishares 20+ Year Treasury Bd | ETF-政府公債 | 1.39% | -1.96% | EXIT | |
| 17 | UTHR | United Therapeutics CORP | 股票-醫療保健 | 1.37% | -0.17% | -66.63% | |
| 18 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 1.33% | +0.05% | +12.84% | |
| 19 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 1.32% | -0.56% | +269.87% | |
| 20 | BRKR | Bruker CORP | 股票-醫療保健 | 1.22% | +0.35% | — | |
| 21 | EW | Edwards Lifesciences CORP | 股票-醫療保健 | 1.12% | — | — | |
| 22 | DXCM | Dexcom Inc | 股票-醫療保健 | 1.03% | — | — | |
| 23 | CNC | Centene CORP | 股票-醫療保健 | 1.01% | -0.19% | EXIT | |
| 24 | TFX | Teleflex Inc | 股票-醫療保健 | 0.98% | — | — | |
| 25 | ELV | Elevance Health Inc | 股票-醫療保健 | 0.96% | — | +49.90% | |
| 26 | PCVX | Vaxcyte Inc | 股票-其他 | 0.93% | -0.93% | — | |
| 27 | TVTX | Travere Therapeutics Inc | 股票-其他 | 0.76% | +1.50% | -43.64% | |
| 28 | CYH | Community Health Systems Inc | 股票-其他 | 0.75% | +0.01% | -67.79% | |
| 29 | GH | Guardant Health Inc | 股票-醫療保健 | 0.75% | — | — | |
| 30 | RGEN | Repligen CORP | 股票-醫療保健 | 0.69% | -0.65% | -66.95% | |
| 31 | IONS | Ionis Pharmaceuticals Inc | 股票-醫療保健 | 0.67% | +0.23% | -54.40% | |
| 32 | FTRE | Fortrea Holdings Inc | 股票-醫療保健 | 0.67% | — | -12.28% | |
| 33 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.63% | — | -10.41% | |
| 34 | AZNN | Astrazeneca Plc-spons Adr | 股票-其他 | 0.60% | — | — | |
| 35 | LQDA | Liquidia CORP | 股票-其他 | 0.60% | +0.42% | +314.14% | |
| 36 | MEDP | Medpace Holdings Inc | 股票-醫療保健 | 0.56% | — | — | |
| 37 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 0.54% | +0.22% | — | |
| 38 | MNKD | Mannkind CORP | 股票-其他 | 0.52% | — | -54.28% | |
| 39 | HUM | Humana Inc | 股票-醫療保健 | 0.51% | +0.64% | NEW | |
| 40 | HSIC | Henry Schein Inc | 股票-醫療保健 | 0.49% | — | — | |
| 41 | DHR | Danaher CORP | 股票-醫療保健 | 0.45% | — | -42.21% | |
| 42 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.40% | -0.38% | -91.64% | |
| 43 | PDCOEUR | Patterson Cos Inc | 股票-其他 | 0.40% | — | — | |
| 44 | GOSS | Gossamer Bio Inc | 股票-其他 | 0.40% | — | — | |
| 45 | EOLS | Evolus Inc | 股票-其他 | 0.38% | — | -15.45% | |
| 46 | ICLR | ICON Public Limited Company | 股票-醫療保健 | 0.36% | -0.40% | EXIT | |
| 47 | SUPN | Supernus Pharmaceuticals Inc | 股票-醫療保健 | 0.34% | — | — | |
| 48 | AVTR | Avantor Inc | 股票-醫療保健 | 0.31% | -1.23% | EXIT | |
| 49 | PBYI | Puma Biotechnology Inc | 股票-其他 | 0.27% | — | -22.98% | |
| 50 | TSVT* | 2seventy Bio Inc | 股票-其他 | 0.26% | — | +0.56% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | +4.8% | +0.76% | 加碼 |
| 2 | QQQ | Invesco Qqq Trust Series 1 | +2.7% | -2.60% | 減碼 |
| 3 | HQY | Healthequity Inc | +1.5% | +21.19% | 加碼 |
| 4 | TLT | Ishares 20+ Year Treasury Bd | +1.4% | NEW | 新建倉 |
| 5 | BRKR | Bruker CORP | +1.2% | NEW | 新建倉 |
| 6 | EW | Edwards Lifesciences CORP | +1.1% | NEW | 新建倉 |
| 7 | HCA | Hca Healthcare Inc | +1.1% | +36.20% | 加碼 |
| 8 | BCRX | Biocryst Pharmaceuticals Inc | +1% | +269.87% | 加碼 |
| 9 | DXCM | Dexcom Inc | +1% | NEW | 新建倉 |
| 10 | TFX | Teleflex Inc | +1% | NEW | 新建倉 |
| 11 | PTGX | Protagonist Therapeutics Inc | +1% | +52.47% | 加碼 |
| 12 | PCVX | Vaxcyte Inc | +0.9% | NEW | 新建倉 |
| 13 | INSP | Inspire Medical Systems Inc | +0.9% | +6.53% | 加碼 |
| 14 | GH | Guardant Health Inc | +0.8% | NEW | 新建倉 |
| 15 | AZNN | Astrazeneca Plc-spons Adr | +0.6% | NEW | 新建倉 |
| 16 | MEDP | Medpace Holdings Inc | +0.6% | NEW | 新建倉 |
| 17 | XENE | Xenon Pharmaceuticals Inc | +0.5% | NEW | 新建倉 |
| 18 | LQDA | Liquidia CORP | +0.5% | +314.14% | 加碼 |
| 19 | HSIC | Henry Schein Inc | +0.5% | NEW | 新建倉 |
| 20 | TEVA | Teva Pharmaceutical-sp Adr | +0.4% | -30.68% | 減碼 |
| 21 | PDCOEUR | Patterson Cos Inc | +0.4% | NEW | 新建倉 |
| 22 | SUPN | Supernus Pharmaceuticals Inc | +0.3% | NEW | 新建倉 |
| 23 | ZIMV | Zimvie Inc | +0.3% | — | 不變 |
| 24 | CNC | Centene CORP | +0.3% | +39.67% | 加碼 |
| 25 | CLDX | Celldex Therapeutics Inc | +0.3% | +27.43% | 加碼 |
| 26 | NAMS | NewAmsterdam Pharma Company N.V. | +0.3% | -10.41% | 減碼 |
| 27 | ELV | Elevance Health Inc | +0.3% | +49.90% | 加碼 |
| 28 | VRDN | Viridian Therapeutics Inc | +0.3% | +12.84% | 加碼 |
| 29 | XRAY | Dentsply Sirona Inc | +0.2% | NEW | 新建倉 |
| 30 | 2662247D | Iteos Therapeutics Inc | +0.2% | NEW | 新建倉 |
| 31 | ICLR | ICON Public Limited Company | +0.1% | +40.85% | 加碼 |
| 32 | GOSS | Gossamer Bio Inc | +0.1% | — | 不變 |
| 33 | XOMA | Xoma Royalty Corporation | +0.1% | +1.20% | 加碼 |
| 34 | VTRS | Viatris Inc | 0% | -26.31% | 減碼 |
| 35 | FTRE | Fortrea Holdings Inc | 0% | -12.28% | 減碼 |
| 36 | PBYI | Puma Biotechnology Inc | 0% | -22.98% | 減碼 |
| 37 | ZLAB | Zai Lab Ltd-adr | 0% | -23.88% | 減碼 |
| 38 | ✓ | Merus N V | 0% | — | 不變 |
| 39 | MREO | Mereo Biopharma Group Pl-adr | 0% | — | 不變 |
| 40 | AVTR | Avantor Inc | 0% | — | 不變 |
| 41 | ABSI | Absci CORP | 0% | -26.90% | 減碼 |
| 42 | ACIU | AC Immune SA | 0% | EXIT | 清倉 |
| 43 | STOK | Stoke Therapeutics Inc | 0% | EXIT | 清倉 |
| 44 | ✓ | Affimed N V | 0% | EXIT | 清倉 |
| 45 | TSVT* | 2seventy Bio Inc | -0.1% | +0.56% | 加碼 |
| 46 | IFRX | InflaRx N.V. | -0.1% | -69.64% | 減碼 |
| 47 | TVTX | Travere Therapeutics Inc | -0.1% | -43.64% | 減碼 |
| 48 | ✓ | Amarin Corp PLC | -0.1% | -54.17% | 減碼 |
| 49 | ✓ | -0.1% | EXIT | 清倉 | |
| 50 | AUTL | Autolus Therapeutics PLC | -0.1% | -75.68% | 減碼 |
根據 SEC 官方 Form 13F 申報備案，Eversept Partners, LP 在 Q4 2024 季度的美股持倉總市值約為 US$19.3億，共申報了 65 個公開持股部位。
在 Q4 2024 季度，Eversept Partners, LP 按市值排列的前三大核心持股分別為：NTRA (12.3%)、QQQ (11.0%)、GSK (11.0%)。其中最大持股部位 NTRA 佔據整體投資組合約 12.3% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
TLT
市值: US$1566.7萬
本季最大獲利了結 / 清倉標的
INSM
前期市值: US$7952.6萬
在 Q4 2024 季度中，Eversept Partners, LP 共進行了 77 項持倉異動，包含新建倉 15 個部位、加碼 14 個部位、減碼 31 個部位以及清倉 17 個部位。 其中最大新建倉標的為 TLT。 本季清倉部位包含 INSM。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。